Resources for Patients

The American Cancer Society Multiple Endocrine Neoplasia Type 2 (MEN2) Thyroid Cancer Consortium was created to advance research in the field of thyroid cancer and multiple endocrine neoplasia type 2 (MEN2). This consortium brings together expert scientists and physicians from across the nation to promote discovery in research, to train the clinicians and research leaders of the future, and to develop cutting edge therapies for patients with MEN2 and thyroid cancer.

Contact

International Thyroid Oncology Group
5166 Commercial Drive
Yorkville, New York 13495